BCAB
Price
$2.83
Change
-$0.27 (-8.71%)
Updated
May 17, 6:59 PM EST
82 days until earnings call
CTMX
Price
$1.89
Change
-$0.11 (-5.50%)
Updated
May 17, 6:59 PM EST
81 days until earnings call
Ad is loading...

BCAB vs CTMX

Header iconBCAB vs CTMX Comparison
Open Charts BCAB vs CTMXBanner chart's image
BioAtla
Price$2.83
Change-$0.27 (-8.71%)
Volume$377.54K
CapitalizationN/A
CytomX Therapeutics
Price$1.89
Change-$0.11 (-5.50%)
Volume$2.08M
CapitalizationN/A
View a ticker or compare two or three
BCAB vs CTMX Comparison Chart

Loading...

BCABDaily Signal changed days agoGain/Loss if shorted
 
Show more...
CTMXDaily Signal changed days agoGain/Loss if shorted
 
Show more...
VS
BCAB vs. CTMX commentary
May 19, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BCAB is a StrongSell and CTMX is a StrongSell.

COMPARISON
Comparison
May 19, 2024
Stock price -- (BCAB: $2.83 vs. CTMX: $1.89)
Brand notoriety: BCAB and CTMX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BCAB: 78% vs. CTMX: 48%
Market capitalization -- BCAB: $136.17M vs. CTMX: $147.27M
BCAB [@Biotechnology] is valued at $136.17M. CTMX’s [@Biotechnology] market capitalization is $147.27M. The market cap for tickers in the [@Biotechnology] industry ranges from $586.12B to $0. The average market capitalization across the [@Biotechnology] industry is $2.73B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BCAB’s FA Score shows that 0 FA rating(s) are green whileCTMX’s FA Score has 0 green FA rating(s).

  • BCAB’s FA Score: 0 green, 5 red.
  • CTMX’s FA Score: 0 green, 5 red.
According to our system of comparison, CTMX is a better buy in the long-term than BCAB.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BCAB’s TA Score shows that 4 TA indicator(s) are bullish while CTMX’s TA Score has 3 bullish TA indicator(s).

  • BCAB’s TA Score: 4 bullish, 5 bearish.
  • CTMX’s TA Score: 3 bullish, 7 bearish.
According to our system of comparison, BCAB is a better buy in the short-term than CTMX.

Price Growth

BCAB (@Biotechnology) experienced а +4.43% price change this week, while CTMX (@Biotechnology) price change was -4.55% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +1.41%. For the same industry, the average monthly price growth was +2.86%, and the average quarterly price growth was +60.72%.

Reported Earning Dates

BCAB is expected to report earnings on Aug 08, 2024.

CTMX is expected to report earnings on Aug 07, 2024.

Industries' Descriptions

@Biotechnology (+1.41% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
A.I.dvisor published
a Summary for BCAB with price predictions.
OPEN
A.I.dvisor published
a Summary for CTMX with price predictions.
OPEN
FUNDAMENTALS
Fundamentals
CTMX($147M) has a higher market cap than BCAB($136M). CTMX YTD gains are higher at: 21.935 vs. BCAB (15.041).
BCABCTMXBCAB / CTMX
Capitalization136M147M93%
EBITDAN/AN/A-
Gain YTD15.04121.93569%
P/E RatioN/A9.00-
RevenueN/AN/A-
Total CashN/AN/A-
Total DebtN/AN/A-
FUNDAMENTALS RATINGS
CTMX: Fundamental Ratings
CTMX
OUTLOOK RATING
1..100
50
VALUATION
overvalued / fair valued / undervalued
1..100
56
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
99
PRICE GROWTH RATING
1..100
42
P/E GROWTH RATING
1..100
62
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
BCABCTMX
RSI
ODDS (%)
Bullish Trend 2 days ago
85%
Bearish Trend 2 days ago
88%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
75%
Momentum
ODDS (%)
Bearish Trend 2 days ago
85%
Bearish Trend 2 days ago
84%
MACD
ODDS (%)
Bullish Trend 2 days ago
86%
Bearish Trend 2 days ago
80%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
81%
Bearish Trend 2 days ago
87%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
80%
Bullish Trend 2 days ago
77%
Advances
ODDS (%)
Bullish Trend 3 days ago
82%
Bullish Trend 3 days ago
77%
Declines
ODDS (%)
Bearish Trend 6 days ago
90%
Bearish Trend 6 days ago
87%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
81%
Aroon
ODDS (%)
N/A
Bearish Trend 2 days ago
84%
View a ticker or compare two or three
Ad is loading...
BCABDaily Signal changed days agoGain/Loss if shorted
 
Show more...
CTMXDaily Signal changed days agoGain/Loss if shorted
 
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
PIIPX11.880.05
+0.42%
Principal International Equity Index R4
DPRSX12.480.02
+0.16%
Delaware Global Listed Real Assets Inst
AXMIX14.800.02
+0.14%
Acclivity Mid Cap Multi-Style I
GEQYX54.300.07
+0.13%
GuideStone Funds Equity Index Instl
TSVAX18.560.02
+0.11%
PGIM Quant Solutions Small-Cap Val A

BCAB and

Correlation & Price change

A.I.dvisor indicates that over the last year, BCAB has been loosely correlated with CTMX. These tickers have moved in lockstep 44% of the time. This A.I.-generated data suggests there is some statistical probability that if BCAB jumps, then CTMX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BCAB
1D Price
Change %
BCAB100%
-8.71%
CTMX - BCAB
44%
Loosely correlated
-5.50%
STRO - BCAB
44%
Loosely correlated
-3.37%
CYTK - BCAB
41%
Loosely correlated
-0.65%
AXON - BCAB
41%
Loosely correlated
-0.57%
STOK - BCAB
41%
Loosely correlated
-0.93%
More

CTMX and

Correlation & Price change

A.I.dvisor indicates that over the last year, CTMX has been loosely correlated with TECH. These tickers have moved in lockstep 52% of the time. This A.I.-generated data suggests there is some statistical probability that if CTMX jumps, then TECH could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CTMX
1D Price
Change %
CTMX100%
-5.50%
TECH - CTMX
52%
Loosely correlated
+1.16%
BCAB - CTMX
45%
Loosely correlated
-8.71%
MLEC - CTMX
42%
Loosely correlated
N/A
PYXS - CTMX
39%
Loosely correlated
-0.48%
CRBU - CTMX
37%
Loosely correlated
-5.57%
More